Cargando…
Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway
Metastasis is the main cause of lung cancer‐related death. The tumor microenvironment greatly contributes to tumor metastasis. Resistin, mainly secreted by tumor‐associated macrophages in tumor tissues, is a 12.5‐kDa cysteine‐rich secretory protein that is found at significantly higher levels in the...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113506/ https://www.ncbi.nlm.nih.gov/pubmed/29927028 http://dx.doi.org/10.1111/cas.13704 |
_version_ | 1783351024100048896 |
---|---|
author | Gong, Wei‐Jing Liu, Jun‐Yan Yin, Ji‐Ye Cui, Jia‐Jia Xiao, Di Zhuo, Wei Luo, Chao Liu, Rui‐Jie Li, Xi Zhang, Wei Zhou, Hong‐Hao Liu, Zhao‐Qian |
author_facet | Gong, Wei‐Jing Liu, Jun‐Yan Yin, Ji‐Ye Cui, Jia‐Jia Xiao, Di Zhuo, Wei Luo, Chao Liu, Rui‐Jie Li, Xi Zhang, Wei Zhou, Hong‐Hao Liu, Zhao‐Qian |
author_sort | Gong, Wei‐Jing |
collection | PubMed |
description | Metastasis is the main cause of lung cancer‐related death. The tumor microenvironment greatly contributes to tumor metastasis. Resistin, mainly secreted by tumor‐associated macrophages in tumor tissues, is a 12.5‐kDa cysteine‐rich secretory protein that is found at significantly higher levels in the serum or plasma of cancer patients compared with healthy controls. In this study, we explored the expression and role of resistin in lung adenocarcinoma. Our study showed that resistin was strongly expressed in lung adenocarcinoma tissues and promoted the migration and invasion of lung adenocarcinoma cells in a dose‐dependent manner. Toll‐like receptor 4 (TLR4) was the functional receptor of resistin for migration and invasion in A549 cells. Src/epidermal growth factor receptor (EGFR) was involved in resistin‐induced migration and invasion. Resistin increased the phosphorylation of EGFR through the TLR4/Src pathway. We also found that PI3K/nuclear factor (NF)‐κB were the intracellular downstream effectors mediating resistin‐induced migration and invasion. Taken together, our results suggested that resistin promoted lung adenocarcinoma metastasis through the TLR4/Src/EGFR/PI3K/NF‐κB pathway. |
format | Online Article Text |
id | pubmed-6113506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61135062018-09-04 Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway Gong, Wei‐Jing Liu, Jun‐Yan Yin, Ji‐Ye Cui, Jia‐Jia Xiao, Di Zhuo, Wei Luo, Chao Liu, Rui‐Jie Li, Xi Zhang, Wei Zhou, Hong‐Hao Liu, Zhao‐Qian Cancer Sci Original Articles Metastasis is the main cause of lung cancer‐related death. The tumor microenvironment greatly contributes to tumor metastasis. Resistin, mainly secreted by tumor‐associated macrophages in tumor tissues, is a 12.5‐kDa cysteine‐rich secretory protein that is found at significantly higher levels in the serum or plasma of cancer patients compared with healthy controls. In this study, we explored the expression and role of resistin in lung adenocarcinoma. Our study showed that resistin was strongly expressed in lung adenocarcinoma tissues and promoted the migration and invasion of lung adenocarcinoma cells in a dose‐dependent manner. Toll‐like receptor 4 (TLR4) was the functional receptor of resistin for migration and invasion in A549 cells. Src/epidermal growth factor receptor (EGFR) was involved in resistin‐induced migration and invasion. Resistin increased the phosphorylation of EGFR through the TLR4/Src pathway. We also found that PI3K/nuclear factor (NF)‐κB were the intracellular downstream effectors mediating resistin‐induced migration and invasion. Taken together, our results suggested that resistin promoted lung adenocarcinoma metastasis through the TLR4/Src/EGFR/PI3K/NF‐κB pathway. John Wiley and Sons Inc. 2018-07-20 2018-08 /pmc/articles/PMC6113506/ /pubmed/29927028 http://dx.doi.org/10.1111/cas.13704 Text en © 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Gong, Wei‐Jing Liu, Jun‐Yan Yin, Ji‐Ye Cui, Jia‐Jia Xiao, Di Zhuo, Wei Luo, Chao Liu, Rui‐Jie Li, Xi Zhang, Wei Zhou, Hong‐Hao Liu, Zhao‐Qian Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway |
title | Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway |
title_full | Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway |
title_fullStr | Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway |
title_full_unstemmed | Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway |
title_short | Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway |
title_sort | resistin facilitates metastasis of lung adenocarcinoma through the tlr4/src/egfr/pi3k/nf‐κb pathway |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113506/ https://www.ncbi.nlm.nih.gov/pubmed/29927028 http://dx.doi.org/10.1111/cas.13704 |
work_keys_str_mv | AT gongweijing resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT liujunyan resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT yinjiye resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT cuijiajia resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT xiaodi resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT zhuowei resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT luochao resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT liuruijie resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT lixi resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT zhangwei resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT zhouhonghao resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway AT liuzhaoqian resistinfacilitatesmetastasisoflungadenocarcinomathroughthetlr4srcegfrpi3knfkbpathway |